Resources

Client Alerts, News Articles, Blog Posts, & Multimedia

Everything you need to know about BMD and the industry.

Medicare Making Changes to Improve Behavioral Health Care Access

Client Alert

The Centers for Medicare & Medicaid Services (CMS) recently announced changes to Medicare beneficiaries’ ability to access behavioral health care.

Currently, Medicare covers psychiatric hospitalization for people with acute psychiatric needs, partial hospitalization program services, and outpatient mental health treatment and therapy services. As mental health diagnoses for Medicare-eligible Americans increase, there has been a notable gap in coverage for certain services and certain providers.

In response, Medicare has implemented the following changes:

  1. Permitting Marriage and Family Therapists and Mental Health Counselors (including alcohol and drug counselors who meet the Mental Health Counselor requirements) to independently enroll in Medicare. To date, these providers could not independently enroll as Medicare providers.
  2. Paying for Community Health Integration and Principal Illness Navigation services. Notably, CMS is permitting these services to be provided by community health workers and peer support specialists. These services are especially important for beneficiaries whose social needs (i.e., food, housing, and transportation) interfere with their receipt of health care.
  3. Changing the required level of supervision for behavioral health services performed at federally qualified health centers (FQHCs) and rural health clinics (RHCs). Now, certain behavioral health services at FQHCs and RHCs can be provided with “general” supervision instead of “direct” supervision. Practically, this means that behavioral health providers can now provide certain vital services without a doctor or advanced practice practitioner physically present on-site.
  4. Increasing reimbursement for crisis psychotherapy services to 150% of the usual Physician Fee Schedule rate when crisis care is provided outside of health care settings (i.e., in the community).
  5. Increasing reimbursement for substance use disorder treatment provided in an office setting to better reflect the actual costs of the services.

These changes are part of the 2024 Physician Fee Schedule Final Rule, 2024 Hospital Outpatient Prospective Payment and Ambulatory Surgical Center Payment Systems Final Rule, and 2025 Proposed Medicare Advantage and Part D rules.

If you have questions about expanded Medicare coverage and what that means for your patients or organization, or Medicare coverage of behavioral health services, please contact Member Daphne Kackloudis at dlkackloudis@bmdllc.com or Associate Jordan Burdick at jaburdick@bmdllc.com.


Ohio Board of Pharmacy Update: Key Regulatory Changes and Proposals You Need to Know

The Ohio Board of Pharmacy (BOP) has rescinded certain OAC rules (OAC 4729:5-18-01 through 4729:5-18-06), removing regulations on office-based opioid treatment (OBOT) clinics. The rescissions took effect on June 3, 2024. The BOP also published a new rule, OAC 4729:8-5-01, which sets explicit reporting guidelines for licensed dispensaries and became effective on June 7, 2024.

LGBTQIA+ Patients and Discrimination in Healthcare

In early April, the Kaiser Family Foundation released a study outlining the challenges that LGBT adults face in the United States related to healthcare. According to the study, LGBT patients are “twice as likely as non-LGBT adults to report negative experiences while receiving health care in the last three years, including being treated unfairly or with disrespect (33% v. 15%) or having at least one of several other negative experiences with a provider (61% v. 31%), including a provider assuming something about them without asking, suggesting they were personally to blame for a health problem, ignoring a direct request or question, or refusing to prescribe needed pain medication.”

Ohio Recovery Housing Overhaul: New Standards and Certification Requirements Reshape Sober Living Spaces

Ensuring Fair Access: SB 269 Protects Affordable Medication for Low-Income Patients

SB 269, introduced on December 19, 2023, will ensure that 340B covered entities, including Federally Qualified Health Centers, Ryan White Clinics, disproportionate share hospitals, and Title X clinics, can acquire 340B drugs without facing undue restrictions or discriminatory practices from drug manufacturers and distributors. This protection is crucial for 340B covered entities to continue to provide affordable medications and comprehensive services to low-income patients.

Unveiling Ohio's Pharmacy Board Updates for Distributors, Mobile Clinics, and Controlled Substances

The Ohio Board of Pharmacy will hold a public hearing on May 28, 2024, to discuss several proposed changes and additions to Ohio Administrative Code (OAC). These changes pertain to terminal distributors of dangerous drugs (TDDDs), mobile clinics or medication units, and the classification of controlled substances.